This article is more than 5 years old. Information may no longer be current.
VIDEO: Experts discuss challenging aspects of endovascular therapy
Click Here to Manage Email Alerts
Cardiology Today’s Intervention was on-site at the International Symposium on Endovascular Therapy (ISET) and had the opportunity meet with some of the leading minds in the field.
In this video exclusive, we asked Jihad A. Mustapha, MD, FACC, FSCAI, from Advanced Cardiac and Vascular Amputation Centers in Grand Rapids, Michigan, Cardiology Today’s Intervention Editorial Board Member Michael R. Jaff, DO, FSCAI, from Newton-Wellesley Hospital in Newton, Massachusetts and Harvard Medical School, and William A. Gray, MD, from Main Line Health and Lankenau Heart Institute in Wynnewood, Pennsylvania their thoughts on the most challenging aspects of vascular intervention.
Watch for more.
Disclosures: Gray reports he consults for Abbott Vascular, Boston Scientific, Cardiovascular Systems Inc., Cook Medical, Cordis, Medtronic, Shockwave Medical and W.L. Gore and Associates and holds stock in Biocardia, Coherex Medical, Contego Medical and Silk Road Medical. Jaff reports he consults for Abbott Vascular, American Orthotics and Prosthetics Association, Boston Scientific, Cordis/Cardinal Health, Medtronic, Micell and Philips/Volcano and holds stock in Embolitech, Janacare, PQ Bypass, Sano V, Vacutronix, Vascular Therapies and Venarum. Mustapha reports he consults for Abbott Vascular, Bard Peripheral Vascular, Boston Scientific, Cardiovascular Systems Inc., Cook Medical, Medtronic, Spectranetics and Terumo.